Hydralazine Use and Risk of Vasculitis
In this cohort study of adults who were newly prescribed hydralazine, vasculitis associated with hydralazine was rare, despite multiple reported cases. Use of hydralazine is unlikely to be associated with a clinically meaningful increased risk of vasculitis.
Authors
- Manish M. Sood (ORCID: https://orcid.org/0000-0002-9146-2344)
- Mark Canney (ORCID: https://orcid.org/0000-0002-4308-3083)
- Shan Dhaliwal
- Gregory L. Hundemer (ORCID: https://orcid.org/0000-0003-3559-3531)
- Ayub Akbari (ORCID: https://orcid.org/0000-0002-1388-9799)
- Deena Fremont (ORCID: https://orcid.org/0009-0006-8670-2813)
- David Massicotte-Azarniouch
- Vimal K. Derebail
Institutions
- University of North Carolina at Chapel Hill (US)
- University of Ottawa (CA)
- Ottawa Hospital (CA)
- Ottawa Hospital Research Institute (CA)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.1943
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00